TABLE 3.

Comparison of Reportable Human Papillomavirus-associated Cancers and Precancers: Commission on Cancer; National Program of Cancer Registries; and Surveillance, Epidemiology, and End Results^*

Reportable Diagnoses on or After Jan. 1, 2005	COC (Behavior Code of 2 or 3 in ICD-O 3)	SEER (Behavior Code of 2 or 3 in ICD-O 3)	NPCR (Behavior Code of 2 or 3 in ICD-O 3)
Exceptions (not reportable)	• Skin cancers (c44._) with histology 8000–8110 (after Jan. 1, 2003); prior to that date, AJCC stage groups 2–4 in this group were reportable	• Skin cancers (c44._) with histologies 8000–8005, 8010–8046, 8050–8084, and 8090–8110	• Skin cancers (c44._) with histologies 8000–8005, 8010–8046, 8050–8084, and 8090–8110
	• CIS of the cervix and CIN-3 (after Jan. 1, 1996)	• CIS of the cervix and CIN-3 (after Jan. 1, 1996)	• CIS of the cervix and CIN-3 (after Jan. 1, 1996)
	• PIN-3 (after Jan. 1	• PIN-3 (after Jan. 1, 2001)	• PIN-3 (after Jan. 1, 2001)
	• VIN-3 (after Jan. 1, 96)
	• VAIN-3 (after Jan. 1, 1996)
	• AIN (after Jan. 1, 1996)

COC indicates Commission on Cancer; SEER, Surveillance, Epidemiology, and End Results; NPCR, National Program of Cancer Registries; ICD-O 3, International Classification of Diseases for Oncology, 3rd edition; AJCC, American Joint Committee on Cancer; CIS, cervical carcinoma in situ; CIN-3, cervical intraepithelial neoplasia 3; PIN-3, penile intraepithelial neoplasia 3; VIN-3, vulvar intraepithelial neoplasia 3; VAIN-3, vaginal intraepithelial neoplasia 3; AIN, anal intraepithelial neoplasia.

^*See North American Association of Central Cancer Registries, 2006.¹⁸